Literature DB >> 7946763

Physiological rationale for co-treatment with diuretics in heart failure.

J N Cohn1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7946763      PMCID： PMC1025579          DOI： 10.1136/hrt.72.2_suppl.s63

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  20 in total

1.  Chronic vasodilator therapy in the management of cardiogenic shock and intractable left ventricular failure.

Authors:  J N Cohn; K J Mathew; J A Franciosa; J A Snow
Journal:  Ann Intern Med       Date:  1974-12       Impact factor: 25.391

2.  Treadmill exercise in assessment of the functional capacity of patients with cardiac disease.

Authors:  J A Patterson; J Naughton; R J Pietras; R M Gunnar
Journal:  Am J Cardiol       Date:  1972-11       Impact factor: 2.778

3.  Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.

Authors:  C V Leier; P Huss; R D Magorien; D V Unverferth
Journal:  Circulation       Date:  1983-04       Impact factor: 29.690

4.  Increased plasma arginine vasopressin levels in patients with congestive heart failure.

Authors:  S R Goldsmith; G S Francis; A W Cowley; T B Levine; J N Cohn
Journal:  J Am Coll Cardiol       Date:  1983-06       Impact factor: 24.094

5.  Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.

Authors:  T B Levine; G S Francis; S R Goldsmith; A B Simon; J N Cohn
Journal:  Am J Cardiol       Date:  1982-05       Impact factor: 2.778

6.  Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure.

Authors:  J A Franciosa; S R Goldsmith; J N Cohn
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

7.  Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.

Authors:  F Waagstein; A Hjalmarson; E Varnauskas; I Wallentin
Journal:  Br Heart J       Date:  1975-10

8.  Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.

Authors:  J N Cohn; D G Archibald; S Ziesche; J A Franciosa; W E Harston; F E Tristani; W B Dunkman; W Jacobs; G S Francis; K H Flohr
Journal:  N Engl J Med       Date:  1986-06-12       Impact factor: 91.245

9.  Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Results of a multicenter trial. The Pimobendan Multicenter Research Group.

Authors:  S H Kubo; S Gollub; R Bourge; P Rahko; F Cobb; M Jessup; S Brozena; M Brodsky; P Kirlin; J Shanes
Journal:  Circulation       Date:  1992-03       Impact factor: 29.690

10.  Vascular hemodynamic impedance in congestive heart failure.

Authors:  S M Finkelstein; J N Cohn; V R Collins; P F Carlyle; W J Shelley
Journal:  Am J Cardiol       Date:  1985-02-01       Impact factor: 2.778
View more
  2 in total

Review 1.  Clinical case studies in heart failure management.

Authors:  R J MacFadyen; P Shiels; A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1999-03       Impact factor: 4.335

2.  Effect of Shenmai Injection on ventricular diastolic function in patients with chronic heart failure: An assessment by tissue Doppler imaging.

Authors:  Rong-guo Ma; Chun-xia Wang; Yin-hua Shen; Zhi-qiang Wang; Jin-hua Ma; Lie-sheng Huang
Journal:  Chin J Integr Med       Date:  2010-05-16       Impact factor: 1.978
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.